GIS
37
2
JNJ
39
4
HSY
34
3
DOW
47
3
KMX
58
6
CMS
60
2
MTCH
57
2
KMI
73
4
ITW
48
5
KHC
15
4
HES
53
4
GE
64
4
DOV
50
2
DAL
64
3
MKC
53
2
CL
50
3
MUR
43
3
BF.B
35
2
CTAS
42
2
PSX
27
2
GIS
37
2
JNJ
39
4
HSY
34
3
DOW
47
3
KMX
58
6
CMS
60
2
MTCH
57
2
KMI
73
4
ITW
48
5
KHC
15
4
HES
53
4
GE
64
4
DOV
50
2
DAL
64
3
MKC
53
2
CL
50
3
MUR
43
3
BF.B
35
2
CTAS
42
2
PSX
27
2
Financhill
Back

Amicus Therapeutics Stock Predictions

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
47

FOLD
Amicus Therapeutics

Last Price:
$9.78
Seasonality Move:
5.47%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Amicus Therapeutics Stock Forecast

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 23% based on the past 17 years of stock performance.
  • Amicus Therapeutics has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%
  • Is Amicus Therapeutics Stock Undervalued?
    The current Amicus Therapeutics [FOLD] share price is $9.77. The Score for FOLD is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Amicus Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 23% based on the past 17 years of stock performance.

Amicus Therapeutics Stock Rating

Sell
47
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics overpriced?

  • Amicus Therapeutics has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%

Amicus Therapeutics Stock Price History

Is FOLD stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com

52-Week Data

52-Week High:
14.57
52-Week Low:
9.02

Prediction Charts

Market Cap:
2.9B
Price in USD:
9.77
Volume:
1.1M
Beta:
0.99

Technical Analysis

SMA50:
10.42
SMA100:
10.75
SMA200:
10.60
52-Wk Change:
-30.66%

Stock Predictions

  • Is Amicus Therapeutics stock public?
    Yes, Amicus Therapeutics is a publicly traded company.
  • What is the Amicus Therapeutics stock quote today?
    The Amicus Therapeutics stock price is 9.77 USD today.
  • How to buy Amicus Therapeutics stock online?
    You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-6 9.82 9.73 9.97 9.57
Dec-9 9.76 9.83 10.00 9.74
Dec-10 9.87 10.13 10.20 9.82
Dec-11 10.14 10.16 10.36 10.09
Dec-12 10.06 10.15 10.20 10.02
Dec-13 9.85 9.36 9.91 9.30
Dec-16 9.37 9.90 9.99 9.28
Dec-17 9.86 9.89 9.97 9.72
Dec-18 9.87 9.57 9.93 9.42
Dec-19 9.58 9.73 9.87 9.44
Dec-20 9.68 9.80 9.88 9.60
Dec-23 9.73 9.84 9.84 9.67
Dec-24 9.81 9.79 9.86 9.62
Dec-26 9.73 9.77 9.84 9.65

Amicus Therapeutics Earnings

Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amicus Therapeutics Forecast Revenue Growth

Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.19 per share.

* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.